Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.75 -2.47%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics Total Current Liabilities 2011-2024 | RVNC

Annual Total Current Liabilities Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
89.2 M 75.7 M 67.3 M 61 M 41 M 32 M 20.9 M 19.6 M 12 M 10.2 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
89.2 M 10.2 M 42.9 M